DM-Flow/Trio

ANS/DPN/PAD

Diabetes 3 Devices (6 billing codes)

The DM Flow/Trio are three (3) individual and evidence-based FDA Cleared modalities that identify and measure the autonomic nervous system (ANS), diabetic peripheral neuropathy (DPN), and peripheral arterial disease (PAD). 

Statistically Significant Reductions

Features of the tests:

3 Test with 6 Billing Codes

The DM Flow/Trio are three (3) individual medical devices with three (3) individual reports (as required by CMS) with the following features: 


Both Diabetic Foot Exams are Reimbursable by Medicare

1. Diabetic Neuropathy Device™ www.DPNtest.org is the First FDA Cleared Multi-Objective Innovation that Identifies and Measures Peripheral Neuropathy.  

Identify Heart Attacks and Strokes Early

2. Autonomic Nervous System (ANS) www.ANStest.org device is FDA Cleared and Measures Arterial Stiffness, Vascularization, and Endothelial Function.

Prevent Lower-Extremity Amputations

3. TruPAD™ www.TruPAD.org is a medical device that measures Peripheral Artery Disease (PAD), a condition in which the large and medium-sized arteries supply blood to the legs and become narrow or clogged with plaque, constricting blood flow. 

Major Causes

Get Tested If

Competitive Advantages

Simply Better